141 related articles for article (PubMed ID: 36104592)
1. Patient life aspirations in the context of Duchenne Muscular Dystrophy: a mixed-methods case-control study.
Schwartz CE; Biletch E; Stuart RBB; Rapkin BD
J Patient Rep Outcomes; 2022 Sep; 6(1):97. PubMed ID: 36104592
[TBL] [Abstract][Full Text] [Related]
2. Siblings' life aspirations in the context of Duchenne muscular dystrophy: a mixed-methods case-control study.
Schwartz CE; Biletch E; Stuart RBB; Rapkin BD
J Patient Rep Outcomes; 2022 Sep; 6(1):96. PubMed ID: 36087166
[TBL] [Abstract][Full Text] [Related]
3. Toward patient-centered treatment goals for duchenne muscular dystrophy: insights from the "Your Voice" study.
Schwartz CE; Jackson S; Valentine J; Miller N; Lowes L; Edwards D; McSherry C; Savva D; Lowe A; McSherry J; Engel P
Orphanet J Rare Dis; 2023 Apr; 18(1):90. PubMed ID: 37081508
[TBL] [Abstract][Full Text] [Related]
4. Refining a Web-based goal assessment interview: item reduction based on reliability and predictive validity.
Schwartz CE; Li J; Rapkin BD
Qual Life Res; 2016 Sep; 25(9):2201-12. PubMed ID: 26961007
[TBL] [Abstract][Full Text] [Related]
5. Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods: The DMD-QoL.
Powell PA; Carlton J; Rowen D; Chandler F; Guglieri M; Brazier JE
Neurology; 2021 May; 96(19):e2438-e2450. PubMed ID: 33785551
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
Thongsing A; Likasitwattanakul S; Sanmaneechai O
Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the quality-of-life impact of Duchenne muscular dystrophy on caregivers: a case-control investigation.
Schwartz CE; Stark RB; Audhya IF; Gooch KL
J Patient Rep Outcomes; 2021 Nov; 5(1):124. PubMed ID: 34800189
[TBL] [Abstract][Full Text] [Related]
8. Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL.
Rowen D; Powell P; Mukuria C; Carlton J; Norman R; Brazier J
Value Health; 2021 Oct; 24(10):1499-1510. PubMed ID: 34593174
[TBL] [Abstract][Full Text] [Related]
9. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.
Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K
Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260
[TBL] [Abstract][Full Text] [Related]
10. Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health.
Bendixen RM; Senesac C; Lott DJ; Vandenborne K
Health Qual Life Outcomes; 2012 May; 10():43. PubMed ID: 22545870
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy.
Uzark K; King E; Cripe L; Spicer R; Sage J; Kinnett K; Wong B; Pratt J; Varni JW
Pediatrics; 2012 Dec; 130(6):e1559-66. PubMed ID: 23129083
[TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
Bourke JP; Bueser T; Quinlivan R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
[TBL] [Abstract][Full Text] [Related]
13. Development and Economic Evaluation of a Patient-Centered Care Model for Children With Duchenne Muscular Dystrophy: Protocol for a Quasi-Experimental Study.
Sirari T; Suthar R; Singh A; Prinja S; Gupta V; Malviya M; Chauhan AS; Sankhyan N
JMIR Res Protoc; 2023 Apr; 12():e42491. PubMed ID: 37115592
[TBL] [Abstract][Full Text] [Related]
14. Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks.
Schwartz CE; Stark RB; Cella D; Borowiec K; Gooch KL; Audhya IF
Orphanet J Rare Dis; 2021 Nov; 16(1):487. PubMed ID: 34809687
[TBL] [Abstract][Full Text] [Related]
15. Quality of life of patients with Duchenne muscular dystrophy: from adolescence to young men.
Lue YJ; Chen SS; Lu YM
Disabil Rehabil; 2017 Jul; 39(14):1408-1413. PubMed ID: 27347814
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive qualitative framework for health-related quality of life in Duchenne muscular dystrophy.
Powell PA; Carlton J
Qual Life Res; 2023 Jan; 32(1):225-236. PubMed ID: 36050623
[TBL] [Abstract][Full Text] [Related]
17. Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: a mixed-methods study protocol.
Powell PA; Carlton J; Rowen D; Brazier JE
BMJ Open; 2019 Mar; 9(3):e023685. PubMed ID: 30852532
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Alterations in Gait Features in Growing Children With Duchenne Muscular Dystrophy.
Vandekerckhove I; Van den Hauwe M; De Beukelaer N; Stoop E; Goudriaan M; Delporte M; Molenberghs G; Van Campenhout A; De Waele L; Goemans N; De Groote F; Desloovere K
Front Hum Neurosci; 2022; 16():861136. PubMed ID: 35721358
[TBL] [Abstract][Full Text] [Related]
19. Mobile arm supports in Duchenne muscular dystrophy: a pilot study of user experience and outcomes.
Cruz A; Callaway L; Randall M; Ryan M
Disabil Rehabil Assist Technol; 2021 Nov; 16(8):880-889. PubMed ID: 32293211
[TBL] [Abstract][Full Text] [Related]
20. Development and Reliability of the Functional Evaluation Scale for Duchenne Muscular Dystrophy, Gait Domain: A Pilot Study.
de Carvalho EV; Hukuda ME; Escorcio R; Voos MC; Caromano FA
Physiother Res Int; 2015 Sep; 20(3):135-46. PubMed ID: 25521365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
